Today: 16 April 2026
Abercrombie & Fitch stock: what comes next after the 18% plunge on outlook update
13 January 2026
2 mins read

Abercrombie & Fitch stock: what comes next after the 18% plunge on outlook update

NEW YORK, Jan 13, 2026, 04:45 EST — Premarket

  • Shares of Abercrombie & Fitch held steady in premarket, following a sharp 17.7% drop on Monday that pushed the stock down to $102.78.
  • The retailer cut its full-year sales growth forecast while boosting its capital spending plan, citing tariff-related expenses.
  • Investors await further insights from management at the ICR Conference, particularly on the impact of tariffs on margins.

Abercrombie & Fitch (ANF.N) held steady near $102.78 in premarket Tuesday, following a sharp 17.7% drop the previous day. The stock closed Monday at $102.78, with roughly 6.6 million shares exchanged, after the company trimmed some of its guidance.

This shift matters today because the update didn’t signal falling demand — it flagged tighter economics. A small cut to sales growth, weaker margin forecasts, and ramped-up spending can easily unsettle a retail stock riding high on expectations.

The news came as retailers gathered with investors at the ICR Conference, a time when companies frequently trim guidance and the market digs for clues about the holiday season’s true impact. Traders are focused on whether pricing will turn more promotional and if cost pressures, rather than sales, will dominate the narrative heading into 2026.

Abercrombie cut its fiscal 2025 net sales growth forecast to at least 6%, down from the previous 6% to 7% range, according to an 8-K filing. The company now anticipates an operating margin near 13%, slightly below the prior 13.0% to 13.5% estimate. It left its full-year share repurchase plan steady at about $450 million but raised capital spending to roughly $245 million. Full-year earnings guidance tightened to a range of $10.30 to $10.40 per share. For Q4, Abercrombie projects net sales growth around 5% and earnings between $3.50 and $3.60 per share. CEO Fran Horowitz noted the company posted “record quarter-to-date net sales through fiscal December.” The forecast factors in roughly $90 million in tariff costs, which equate to about 170 basis points (1.7 percentage points) of sales after mitigation. SEC

Sentiment across the sector leaned cautious. American Eagle and Urban Outfitters both signaled slower holiday-quarter sales. Consumer Edge analyst Michael Gunther noted the “theme of value-seeking behavior was on full display in this morning’s slew of retail pre-announcements,” reflecting investor concerns over full-price sales and inventory control. Reuters

Abercrombie’s story flipped quickly—from “how high can growth climb” to “how solid are the margins.” The sales adjustment was minor, yet the margin cut and a clear tariff line caught sellers’ attention.

Some investors are betting on a rebound after the single-day selloff. Others want to see evidence the company can maintain pricing power even as it ramps up spending on stores and digital, without costs outpacing demand.

The downside is straightforward: if promotions ramp up after the holidays or tariffs shift again, that margin buffer could shrink fast. A more volatile consumer environment would only make it tougher to compensate through volume.

Insights will hinge on what management reveals — and leaves unsaid — during investor sessions at the ICR Conference running through Tuesday. Focus centers on tariff mitigation efforts and whether Q4 momentum persisted into January. With the fiscal year closing Jan. 31, all eyes are on the last stretch of results and upcoming guidance.

Stock Market Today

  • TKO Group Holdings Shares Fall Below 200-Day Moving Average
    April 15, 2026, 9:06 PM EDT. Shares of TKO Group Holdings Inc (TKO) dipped below their 200-day moving average of $193.74 during Wednesday trading, touching a low of $192.22. The stock closed down around 1.4% for the day. Its current price, $192.85, sits between a 52-week low of $141.44 and a high of $226.94. The 200-day moving average is a key technical indicator that smooths out price data to identify long-term trends. This move could signal a potential shift in investor sentiment on TKO shares after recent performance fluctuations.

Latest article

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

16 April 2026
Norse Atlantic Airways has canceled all planned summer flights from Los Angeles to London Gatwick, Paris, and Rome, citing surging jet fuel costs. The airline launched a $110 million rights issue, secured a $70 million bridge loan, and withdrew its 2026 outlook. Routes disappeared from booking systems on April 14. Norse had been the only scheduled operator on the Gatwick-Los Angeles route.
S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

16 April 2026
The S&P 500 closed at a record 7,022.95 and the Nasdaq at 24,016.02 on Wednesday, erasing losses from the March selloff tied to the Feb. 28 conflict. Bank of America reported $8.6 billion in first-quarter net income, up 17%, while Morgan Stanley posted record revenue. Talks between Washington and Tehran raised hopes for easing oil supply fears, but Brent crude stayed elevated at $94.93 a barrel.
Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

16 April 2026
China is considering export restrictions on advanced solar-manufacturing equipment to the U.S., potentially affecting Tesla’s plans for new factories, sources told Reuters. Tesla aims to buy $2.9 billion in solar-panel equipment from China and expand U.S. solar production. China produces over 80% of global solar panel components. No final decision has been made, and consultations remain preliminary.
Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

15 April 2026
Hims & Hers Health shares rose 14% to $24.29 after the FDA said it will review restrictions on several peptides, including BPC-157 and TB-500. The agency set a July advisory meeting and will remove some peptides from its safety-risk list within a week. Hims, which acquired a California peptide facility last year, reported $2.35 billion in 2025 revenue and 2.511 million subscribers.
Locked out of $22B: Canadian real estate funds freeze withdrawals as gates spread
Previous Story

Locked out of $22B: Canadian real estate funds freeze withdrawals as gates spread

Alibaba stock price today: BABA in focus after 10% jump on China “AI+ Manufacturing” push
Next Story

Alibaba stock price today: BABA in focus after 10% jump on China “AI+ Manufacturing” push

Go toTop